Home » Topics » BioWorld Science

BioWorld Science
RSS

Redox-tuned [18F]4FN radiopharmaceutical is useful for imaging innate immunity activation

Feb. 25, 2022

Risk SNP for COVID-19 signals protection against HIV

Feb. 24, 2022

GliaPharm and Wyss Center collaborate on new treatments for Alzheimer's disease

Feb. 24, 2022

IL-9/ARG1/macrophage axis targeting for the treatment of allergic airway inflammation

Feb. 24, 2022

Identification of novel antifungal and antibacterial compounds

Feb. 24, 2022

ConserV receives funding to advance pan-coronavirus vaccine candidate UNICOR-v

Feb. 24, 2022

Jnana selects JNT-517 as development candidate for phenylketonuria

Feb. 24, 2022

Financing at Plexium supports progression of pipeline of targeted protein degradation therapies

Feb. 24, 2022

v7D, varicella vaccine candidate with promising safety and immunogenicity in nonhuman primates

Feb. 24, 2022

Merck & Co. synthesizes new influenza virus Cap-dependent endonuclease inhibitors

Feb. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...